World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
80
Citations
48268
World Ranking
16863
National Ranking
8456

Overview

Sankar D. Navaneethan is affiliated with Baylor College of Medicine in the United States. Their research focuses broadly on medicine, with specific subfields including cardiology and cardiovascular medicine, endocrinology, diabetes and metabolism, nephrology, pulmonary and respiratory medicine, and surgery.

The scientist has contributed extensively to topics such as diabetes treatment and management, blood pressure and hypertension studies, dialysis and renal disease management, chronic kidney disease and diabetes, heart failure treatment and management, diabetes management and research, and potassium and related disorders.

Navaneethan has published numerous papers in several prominent academic journals. Frequent publication venues include:

  • Journal of the American Society of Nephrology
  • American Journal of Kidney Diseases
  • Kidney International
  • Current Opinion in Nephrology & Hypertension
  • Circulation

Collaborations have been a significant part of their research output, with frequent co-authors including L. Parker Gregg, Salim S. Virani, Carl P. Walther, Wolfgang C. Winkelmayer, and Jiang He.

Recent publications feature major updates and reports related to cardiovascular health and diabetes management. Notable papers include:

  • Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association (2022, Circulation)
  • Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association (2023, Circulation)
  • Heart Disease and Stroke Statistics-2021 Update (2021, Circulation)
  • 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association (2024, Circulation)
  • Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline: evidence-based advances in monitoring and treatment (2020, Kidney International)

Best Publications

  • Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association.

    Salim S. Virani;Alvaro Alonso;Hugo J. Aparicio;Emelia J. Benjamin

  • Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes

    Philip R. Schauer;Deepak L. Bhatt;John P. Kirwan;Kathy Wolski

  • Diabetic Kidney Disease: A Report From an ADA Consensus Conference

    Katherine R. Tuttle;George L. Bakris;Rudolf W. Bilous;Jane L. Chiang

  • Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 3-Year Outcomes

    Philip R. Schauer;Deepak L. Bhatt;John P. Kirwan;Kathy Wolski

  • KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease

    Ian H. de Boer;M. Luiza Caramori;Juliana C.N. Chan;Hiddo J.L. Heerspink

  • Metabolic Syndrome and Kidney Disease: A Systematic Review and Meta-analysis

    George Thomas;Ashwini R. Sehgal;Sangeeta R. Kashyap;Titte R. Srinivas

  • Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis

    Navdeep Tangri;Morgan E. Grams;Andrew S. Levey;Josef Coresh

  • Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials

    Giovanni F M Strippoli;Sankar D Navaneethan;David W Johnson;Vlado Perkovic

  • Meta-analysis: Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease

    Suetonia C. Palmer;Sankar D. Navaneethan;Jonathan C. Craig;David W. Johnson

  • Weight Loss Interventions in Chronic Kidney Disease: A Systematic Review and Meta-analysis

    Sankar D. Navaneethan;Hans Yehnert;Fady Moustarah;Martin J. Schreiber

  • Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis.

    Suetonia C. Palmer;Jonathan C. Craig;Sankar D. Navaneethan;Marcello Tonelli

  • Vitamin D Supplementation in Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Observational Studies and Randomized Controlled Trials

    Praveen Kandula;Mirela Dobre;Jesse D. Schold;Martin J. Schreiber

  • Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

    Catherine M. Clase;Juan Jesus Carrero;David H. Ellison;Morgan E. Grams

  • Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease

    Giovanni Fm Strippoli;Carmen Bonifati;Maria E Craig;Sankar D Navaneethan

  • Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies

    Josef Coresh;Hiddo J L Heerspink;Yingying Sang;Kunihiro Matsushita

  • Aldosterone Antagonists for Preventing the Progression of Chronic Kidney Disease: A Systematic Review and Meta-analysis

    Sankar D. Navaneethan;Sagar U. Nigwekar;Ashwini R. Sehgal;Giovanni F.M. Strippoli

  • Fibroblast growth factor 23 and Inflammation in CKD.

    Jair Munoz Mendoza;Tamara Isakova;Ana C. Ricardo;Huiliang Xie

  • HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.

    Suetonia C Palmer;Sankar D Navaneethan;Jonathan C Craig;David W Johnson

  • Sodium Bicarbonate Therapy for Prevention of Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis

    Sankar D. Navaneethan;Sonal Singh;Suresh Appasamy;Richard E. Wing

  • HMG CoA reductase inhibitors (statins) for dialysis patients

    Suetonia C Palmer;Sankar D Navaneethan;Jonathan C Craig;David W Johnson

Frequent Co-Authors

Giovanni F.M. Strippoli
Giovanni F.M. Strippoli University of Sydney
Jonathan C. Craig
Jonathan C. Craig Flinders University
Suetonia C. Palmer
Suetonia C. Palmer University of Otago
John P. Kirwan
John P. Kirwan Pennington Biomedical Research Center
Wolfgang C. Winkelmayer
Wolfgang C. Winkelmayer Baylor College of Medicine
Harold I. Feldman
Harold I. Feldman University of Pennsylvania
Morgan E. Grams
Morgan E. Grams Johns Hopkins University
Vlado Perkovic
Vlado Perkovic George Institute for Global Health
Josef Coresh
Josef Coresh New York University
Alan S. Go
Alan S. Go Kaiser Permanente

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a future in medicine, related online degrees can open new doors and advance your career—often with flexible study options. For instance, pursuing a top cahme accredited mha programs is a great way to transition into healthcare administration, giving you management skills that are essential in hospital and healthcare settings.

Many nurses are opting for online rn to bsn programs no clinicals to boost their credentials without the need for in-person clinical hours, which adds flexibility for working professionals. If you’re aiming for the highest levels of nursing practice, you may consider the fastest msn to dnp program options, allowing you to achieve your doctorate degree quickly.

Some students seek out easy dnp programs to further streamline their educational pathway while still gaining advanced nursing skills.

Selecting the right pathway depends on your goals, current qualifications, and desired work environment. These online programs make it more convenient than ever to take the next step in your healthcare career.

Best Scientists Citing Sankar D. Navaneethan

Trending Scientists

Recently Published Articles